Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

Swallowing problems in post irradiated NPC patients.

Mok P, Seshadri RS, Siow JK, Lim SM.

Singapore Med J. 2001 Jul;42(7):312-6.

PMID:
11599626
2.

Reduction in hyoid bone forward movement in irradiated nasopharyngeal carcinoma patients with dysphagia.

Wang TG, Chang YC, Chen WS, Lin PH, Hsiao TY.

Arch Phys Med Rehabil. 2010 Jun;91(6):926-31. doi: 10.1016/j.apmr.2010.02.011.

PMID:
20510985
3.

Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience.

Lee N, Xia P, Quivey JM, Sultanem K, Poon I, Akazawa C, Akazawa P, Weinberg V, Fu KK.

Int J Radiat Oncol Biol Phys. 2002 May 1;53(1):12-22.

PMID:
12007936
4.

Laryngopharyngeal sensory deficits and impaired pharyngeal motor function predict aspiration in patients irradiated for nasopharyngeal carcinoma.

Ku PK, Vlantis AC, Leung SF, Lee KY, Cheung DM, Abdullah VJ, van Hasselt A, Tong MC.

Laryngoscope. 2010 Feb;120(2):223-8. doi: 10.1002/lary.20701.

PMID:
19950372
5.

Initial experience using intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma.

Lu TX, Mai WY, Teh BS, Zhao C, Han F, Huang Y, Deng XW, Lu LX, Huang SM, Zeng ZF, Lin CG, Lu HH, Chiu JK, Carpenter LS, Grant WH 3rd, Woo SY, Cui NJ, Butler EB.

Int J Radiat Oncol Biol Phys. 2004 Mar 1;58(3):682-7.

PMID:
14967420
6.

Impact of dysphagia on quality-of-life in nasopharyngeal carcinoma.

Lovell SJ, Wong HB, Loh KS, Ngo RY, Wilson JA.

Head Neck. 2005 Oct;27(10):864-72.

PMID:
16114007
7.

Linear accelerator-based stereotactic radiosurgery for limited, locally persistent, and recurrent nasopharyngeal carcinoma: efficacy and complications.

Chua DT, Sham JS, Kwong PW, Hung KN, Leung LH.

Int J Radiat Oncol Biol Phys. 2003 May 1;56(1):177-83.

PMID:
12694836
8.

Prognostic factors and outcome for nasopharyngeal carcinoma.

Farias TP, Dias FL, Lima RA, Kligerman J, de Sá GM, Barbosa MM, Gonçalves FB Jr.

Arch Otolaryngol Head Neck Surg. 2003 Jul;129(7):794-9.

PMID:
12874084
9.

Supracricoid laryngectomy outcomes: The Johns Hopkins experience.

Farrag TY, Koch WM, Cummings CW, Goldenberg D, Abou-Jaoude PM, Califano JA, Flint PW, Webster K, Tufano RP.

Laryngoscope. 2007 Jan;117(1):129-32.

PMID:
17202941
10.
11.

The risk of second primary tumors in patients with nasopharyngeal carcinoma after definitive radiotherapy.

Kong L, Lu JJ, Hu C, Guo X, Wu Y, Zhang Y.

Cancer. 2006 Sep 15;107(6):1287-93.

12.

Nasopharyngeal carcinoma with cranial nerve palsy: the importance of MRI for radiotherapy.

Chang JT, Lin CY, Chen TM, Kang CJ, Ng SH, Chen IH, Wang HM, Cheng AJ, Liao CT.

Int J Radiat Oncol Biol Phys. 2005 Dec 1;63(5):1354-60.

PMID:
16297716
13.

Intensity-modulated radiotherapy of head and neck cancer aiming to reduce dysphagia: early dose-effect relationships for the swallowing structures.

Feng FY, Kim HM, Lyden TH, Haxer MJ, Feng M, Worden FP, Chepeha DB, Eisbruch A.

Int J Radiat Oncol Biol Phys. 2007 Aug 1;68(5):1289-98. Epub 2007 Jun 7.

PMID:
17560051
14.

Predictors of acute grade 4 swallowing toxicity in patients with stages III and IV squamous carcinoma of the head and neck treated with radiotherapy alone.

Poulsen MG, Riddle B, Keller J, Porceddu SV, Tripcony L.

Radiother Oncol. 2008 May;87(2):253-9. doi: 10.1016/j.radonc.2008.03.010. Epub 2008 Apr 12.

PMID:
18410976
15.

Early swallowing problems in a cohort of patients with nasopharyngeal carcinoma: Symptomatology and videofluoroscopic findings.

Ku PK, Yuen EH, Cheung DM, Chan BY, Ahuja A, Leung SF, Tong MC, van Hasselt A.

Laryngoscope. 2007 Jan;117(1):142-6.

PMID:
17202944
16.

[Important prognostic factors in patients with skull base erosion from nasopharyngeal carcinoma after radiotherapy].

Hu Y, Lu T, Mai W, Han F, Huang Y, Liu H, Zhang E.

Zhonghua Er Bi Yan Hou Ke Za Zhi. 2001 Dec;36(6):463-7. Chinese.

PMID:
12761966
17.

Plasma Epstein-Barr virus DNA and residual disease after radiotherapy for undifferentiated nasopharyngeal carcinoma.

Chan AT, Lo YM, Zee B, Chan LY, Ma BB, Leung SF, Mo F, Lai M, Ho S, Huang DP, Johnson PJ.

J Natl Cancer Inst. 2002 Nov 6;94(21):1614-9.

PMID:
12419787
18.

[Long-term efficacy of external radiotherapy plus intracavitary hyperfractionated brachytherapy on nasopharyngeal carcinoma].

Lin SJ, Pan JJ, Wu JX, Han L, Pan CZ.

Ai Zheng. 2007 Feb;26(2):208-11. Chinese.

PMID:
17298755
19.

[Clinical study on radiotherapy-related typing of nasopharyngeal carcinoma].

Li ZQ, Xia YF, Liu Q, Liu XF, Han F, Yi W, Luo W, Lu TX.

Zhonghua Yi Xue Za Zhi. 2006 Dec 12;86(46):3272-6. Chinese.

PMID:
17313809
20.

Prospective phase II trial of concomitant boost radiotherapy for stage II nasopharyngeal carcinoma.

Lu JJ, Kong L, Shakespeare TP, Loh KS, Zhang Q, Tan KS, Lee KM.

Oral Oncol. 2008 Jul;44(7):703-9. Epub 2007 Dec 3.

PMID:
18061528

Supplemental Content

Support Center